Literature DB >> 9541236

Calcium- and hydroxyapatite-binding properties of glucuronic acid-rich and iduronic acid-rich glycosaminoglycans and proteoglycans.

G Embery1, S Rees, R Hall, K Rose, R Waddington, P Shellis.   

Abstract

This study describes the interaction of a small chondroitin sulphate proteoglycan and the glycosaminoglycans chondroitin 4-sulphate, dermatan sulphate and heparan sulphate with hydroxyapatite. All macromolecules possessed a high affinity, with the iduronic acid-rich dermatan sulphate and heparan sulphate displaying higher adsorption maxima than the glucuronic acid-rich chondroitin 4-sulphate. At similar concentrations, dermatan sulphate produced a 30% inhibition of hydroxyapatite-induced crystal growth, whilst chondroitin 4-sulphate yielded 50% inhibition. Estimation of the calcium binding capacity of these glycosaminoglycans using equilibrium dialysis indicated that chondroitin 4-sulphate bound five times more calcium than dermatan sulphate at a calcium concentration similar to that of serum. The data indicate a possible important role for chondroitin 4-sulphate in dentinogenesis where it is the dominant glycosaminoglycan, since it could act as a capture point for calcium ions during mineralisation, with the leucine-rich domain of its parent proteoglycan acting as anchor points to type I collagen.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9541236     DOI: 10.1111/j.1600-0722.1998.tb02186.x

Source DB:  PubMed          Journal:  Eur J Oral Sci        ISSN: 0909-8836            Impact factor:   2.612


  2 in total

Review 1.  A hypothesis of calcium stone formation: an interpretation of stone research during the past decades.

Authors:  Hans-Göran Tiselius
Journal:  Urol Res       Date:  2011-01-19

2.  Osteogenic cell differentiation on H-terminated and O-terminated nanocrystalline diamond films.

Authors:  Jana Liskova; Oleg Babchenko; Marian Varga; Alexander Kromka; Daniel Hadraba; Zdenek Svindrych; Zuzana Burdikova; Lucie Bacakova
Journal:  Int J Nanomedicine       Date:  2015-01-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.